Among 169,649 patients with MASLD, GLP-1 receptor agonist initiation was linked to significantly lower probability of incident cirrhosis [adjusted hazard ratio (aHR): 0.86, 95%CI: 0.80-0.93], hepatic decompensation (aHR: 0.77, 95%CI: 0.65-0.90), and hepatocellular carcinoma (HCC) (aHR: 0.79, 95%CI: 0.68-0.92) over a median follow-up of 3.5 years compared to non-users
Glucagon-like peptide-1 receptor agonist medications and hair loss: a retrospective cohort study
Female predominance in AE reports (65.3% vs 30.5% male) persists despite global diabetes prevalence favoring males 39 , suggesting either biological susceptibility or heightened health-seeking behavior in women
Innovative therapeutic strategies based on GLP-1 receptor agonists (GLP-1RAs), such as tirzepatide, fixed-ratio combinations of GLP-1RA with basal insulin, combinations of GLP-1RA with sodium-glucose cotransporter-2 inhibitors (SGLT-2i), and high-dose GLP-1RAs, have been listed as one of the most effective options for the treatment of type 2 diabetes
So "How much is semaglutide?" isn't a straightforward question